Advertisement
Stocks / Stock overview

Northrop Grumman Corp /de/ (NOC)

$528.24+0.84%Aft $530.50 (+0.43%)Market cap $75.04B

NYSE · Price as of · Delayed Quote

Stock Scorer
Scoring…
Analyst consensus
Buy$647.14
  • Analysts21
  • Implied upside+22.5%
  • Target range$538.00 to $815.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
October 20, 2026before the open
  • EPS expected$7.16 -6.6%
  • A year ago$7.67
  • Revenue expected$11.13B +6.8%
  • Estimate range$6.69 to $7.35
Consensus of 17 analysts for the quarter ending September 30, 2026. Beat the estimate in all four of the last four quarters. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar

How Congress has done in NOC

Source: AIStockWire, scored from STOCK Act disclosures against daily price historyGenerated

Every purchase of NOC disclosed by a member of Congress in the last 5 years, scored over the 12 months after the trade date against SPY over the same window.

MeasureNOCSPY
Median 12-month return after purchase+12.2%+25.4%
Median difference vs SPY-12.2%
Purchases that beat SPY2 of 8 (25%)
Members who bought6

Most frequent buyers: Josh Gottheimer (3), Daniel Goldman (1), Gil Cisneros (1), Lisa McClain (1), Ritchie Torres (1).

These are not returns anyone actually earned. Disclosures report a dollar bracket and no share count, so every purchase is counted once and weighted equally, and sales are not matched back to the buys that opened them. 1 of the 8 purchases are disclosed as a spouse's or dependent's rather than the member's own. Purchases from the last 12 months are excluded because their window has not closed yet.

SEC filings

Source: SEC EDGAR

No current EDGAR filings resolved for NOC. Foreign and over-the-counter listings often do not file with the SEC.

Articles that mention Northrop Grumman without it being the main subject.

Research Innovations wins Army contract worth up to $99.5 million for Nvidia-powered Dragonfly sensors
News

Research Innovations wins Army contract worth up to $99.5 million for Nvidia-powered Dragonfly sensors

The Army awarded Research Innovations Inc. a contract worth up to $99,529,577 to build and sustain Dragonfly spectrum sensors, and received 95 bids for the work. Dragonfly weighs 3.5 pounds and classifies signals onboard using an Nvidia (NVDA) RTX A4500 graphics processor.

Sep 3, 2026

Frequently asked questions

When does NOC report earnings?

Northrop Grumman Corp /de/ (NOC) is scheduled to report quarterly results on October 20, 2026, before the open. The 17-analyst consensus is $7.16 per share on revenue of $11.13B for the quarter ending September 30, 2026, against $7.67 and $10.42B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters.

What do analysts expect for NOC?

21 analysts cover Northrop Grumman Corp /de/ (NOC). The consensus rating is Buy. The average price target is $647.14, in a range of $538.00 to $815.00.

Are insiders buying or selling NOC?

We have no qualifying Form 4 insider purchases or sales on record for Northrop Grumman Corp /de/ (NOC). Sales are only tracked above a dollar threshold, so small routine trades may not appear.

Has Congress made money trading NOC?

6 members of Congress have disclosed buying NOC in the last 5 years, 8 purchases in total. Measured over the 12 months after each trade date, the median purchase returned +12.2% against +25.4% for SPY over the same windows, and 2 of the 8 (25%) beat the index. These are not returns anyone actually earned: congressional disclosures report a dollar bracket and no share count, so each purchase is counted once and weighted equally, and later sales are not matched back to the buys that opened them.

Where can I see NOC SEC filings?

We could not resolve current EDGAR filings for NOC. This usually means the ticker is a foreign or over-the-counter listing that does not file with the SEC.

Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.